Kimmtrak (tebentafusp)

pCPA File Number: 22149

Negotiation Status:

Concluded with an LOI

Indication(s):

Unresectable or metastatic uveal melanoma in adult patients who are Human leukocyte antigen (HLA)-A*02:01-positive

Sponsor/Manufacturer:

Medison Pharma Canada Inc.

CDA-AMC Project Number:

PC0290-000

pCPA Engagement Letter Issued:

2023-05-09

Negotiation Process Concluded:

2023-10-23